Fouling is a natural phenomenon that describes the tendency of proteins in water to adhere to nearby surfaces. It’s what causes unwanted deposits of protein to form during some food production or on biomedical implants, causing them to fail. Researchers at Rensselaer Polytechnic Institute are harnessing this process, which is typically considered a persistent challenge, to develop a versatile and accessible approach for modifying solid surfaces.
A novel form of polymerized estrogen developed at Rensselaer Polytechnic Institute can provide neuroprotection when implanted at the site of a spinal cord injury — preventing further damage. This promising result, found in a preclinical model, was recently published in ACS Chemical Neuroscience, and it lays the groundwork for further advancement of this new biomaterial.
The era of widespread remote learning brought about by the COVID-19 pandemic requires online testing methods that effectively prevent cheating, especially in the form of collusion among students. With concerns about cheating on the rise across the country, a solution that also maintains student privacy is particularly valuable.
Triage care on the battlefield requires split-second decision-making and proficiency in providing first aid. Correctly applying a tourniquet or inserting an intubation tube before a patient is evacuated to a hospital could save lives. To improve training for the field medics responsible for this level of care, researchers at Rensselaer Polytechnic Institute will team up with researchers from the United States Army Research Laboratory in Orlando, Florida, to better understand skill acquisition and to standardize the prolonged field care (PFC) certification process.
Blood sample analysis showed that, two to five years after they gave birth, mothers of children with autism spectrum disorder (ASD) had several significantly different metabolite levels compared to mothers of typically developing children. That’s according to new research recently published in BMC Pediatrics by a multidisciplinary team from Rensselaer Polytechnic Institute, Arizona State University, and the Mayo Clinic.
TROY, N.Y. — A loss of enzymatic processes within the body can increase a person’s risk of bone fracture. This new insight was recently published in eLife by an international team of scientists and engineers led by Deepak Vashishth, the director of the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute.